Podcast

Comparing micro-bypass implant + phaco vs phaco in POAG

Author(s):

David Hutton,Alex Delaney-Gesing
Conferences|AAO

Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.



During AAO 2020, Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.

See more AAO coverage

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
AAO 2024: Weijie Violet Lin, MD, discusses risk factors for epithelium-off cross-linking
Related Content
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
Published: December 19th 2024 | Updated: December 19th 2024

Study validates long-term efficacy of MicroPulse TLT for glaucoma management

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options
December 11th 2024

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Study highlights current and potential roles of AI in glaucoma diagnosis
December 7th 2024

Study highlights current and potential roles of AI in glaucoma diagnosis

PolyActiva’s PA5108 glaucoma implant shows promising results in clinical trial, paving the way for long-term drug delivery
December 3rd 2024

PolyActiva’s PA5108 glaucoma implant shows promising results in clinical trial, paving the way for long-term drug delivery

© 2024 MJH Life Sciences

All rights reserved.